Aug 22,2023 TOP STORY

Mahana Therapeutics Signs Agreement with Consumer Health Division of Bayer to Commercialize Digital Therapeutics

Mahana Therapeutics announced today that the company has entered into a multi-million-dollar distribution and marketing partnership with the Consumer Health division of Bayer to commercialize digital therapeutics. Earlier this year, Bayer announced the launch of a new business unit, Precision Health, focused on delivering new digitally enabled precision health products to market. Bayer is prioritizing development of products that enable people to take greater control of their own personal health through digital solutions that facilitate more informed choices based on personal insights and novel delivery mechanisms. David Evendon-Challis, Head of R&D and Chief Scientific Officer for the Consumer Health division of Bayer added, “Digital therapeutics are a perfect addition to our portfolio of care and tap into new tech-savvy consumers looking for drug-free treatments as well as help eliminate gaps in care provision. We’re excited to partner with Mahana Therapeutics and enter the field of digital therapeutics in consumer health.”

COLLABORATION PARTNERSHIP

#institution

#pdt

#cbt

View Analyst & Ambassador Comments
Go to original news
Jul 31,2023

Wales expands NHS use of AI for cancer diagnosis

The devolved Welsh Government plans to expand the use of an artificial intelligence-powered tool used to spot cancer in biopsy samples, after seeing a 13% increase in prostate cancer detection in a pilot study. The IBEX Galen AI platform will now be trialled in suspected breast cancer as well as prostate cancer cases, and the initial pilot at the Betsi Cadwaladr Health Board in Bangor, North Wales, will be extended to include five more boards across the country. The Galen Prostate AI – developed by Ibex Medical Analytics – became the first AI-based cancer diagnostic to be given a CE Mark in the EU earlier this year under the In Vitro Diagnostic Medical Devices Regulation (IVDR), and the company is working to get the same status for its breast and gastric cancer algorithms.

COLLABORATION PARTNERSHIP

#institution

#ai/software

View Analyst & Ambassador Comments
Go to original news
Aug 08,2023

Early findings of AI study at Frimley Health NHS Foundation Trust show 99.7% accuracy in triaging chest X-rays as normal

Frimley Health NHS Foundation Trust and Qure.ai have announced the early results of a pilot study using an innovative radiology AI solution to read and differentiate between normal and abnormal chest X-rays (CXRs). qXR, a CE class IIb MDR cleared solution developed by Qure, was deployed with the hypothesis to categorise normal x-rays – approximately 40% of the caseload from GP and outpatient requests – and augment overall reporting efficiency. Early results show 99.7% accuracy in triaging CXRs as normal, with the potential to reduce consultant radiologist’s workload by up to 58% by transferring cases to radiographer reporting workload. Additionally, the qXR AI identified all cancer cases, including inconspicuous cancer risk nodules that may traditionally remain unnoticed. This heralds the potential of using AI for early detection and treatment of lung cancer.

COLLABORATION PARTNERSHIP

#institution

#ai/software

View Analyst & Ambassador Comments
Go to original news
Aug 02,2023

Massive Bio Partners with Asklepieia, BeStrong, and Open Health Alliance in Greece to Enhance Cancer Clinical Trial

Massive Bio and Asklepieia will utilize their innovative technologies to provide oncologists and patients unparalleled access to crucial clinical trials, personalized cancer treatments, and reports on adequate therapies. Plans are underway for future collaborations with BeStrong and Open Health Alliance. “Our collaboration with Asklepieia combines precision medicine with AI-driven clinical trial matching, speeding up the introduction of clinical trials in Greece,” Cagatay M. Culcuoglu, COO, CTO, and Co-Founder of Massive Bio said.

COLLABORATION PARTNERSHIP

#institution

#ai/software

#platform

View Analyst & Ambassador Comments
Go to original news
Aug 01,2023

Massive Bio Joins FindHealthClinics – Expanding Online Reach in the Healthcare Sector

Massive Bio has recently been added to FindHealthClinics, a trusted online directory catering to the healthcare and wellness industries. This significant development marks a new chapter for Massive Bio as it joins a community of esteemed institutions, clinics, practitioners, and businesses in the field of healthcare. FindHealthClinics serves as a robust platform that connects individuals actively seeking medical, health, and wellness services with reputable professionals and institutions like Massive Bio. With this inclusion, the company gains access to a vast audience of potential clients looking for advanced medical treatments, holistic therapies, wellness services, and more. By utilizing the platform, Massive Bio can expand its online presence, allowing it to reach a broader audience in search of healthcare solutions.

COLLABORATION PARTNERSHIP

#institution

#platform

View Analyst & Ambassador Comments
Go to original news
Aug 15,2023 TOP STORY

Dario Partners with PlanSource to Offer Employers Easy Access to Proven Digital Health Solutions

DarioHealth announced a new agreement with PlanSource, a leading provider of cloud-based benefits administration and engagement technology, to offer integrated digital health solutions to more than 5 million consumers. The new agreement makes it easy for employers to select and implement Dario's integrated chronic condition management solutions to employee health benefit plans as part of a curated set of benefit solutions in the PlanSource Partner Marketplace. The integration of Dario's solutions into the PlanSource Marketplace creates a seamless digital pathway for employees to engage in solutions.

COLLABORATION PARTNERSHIP

#institution

#coaching

View Analyst & Ambassador Comments
Go to original news
Aug 10,2023

Supporting clinicians with effective digital treatments

Big Health partners with the American Psychological Association to increase awareness of the value and impact of digital treatments in clinical care delivery. Last week, Big Health announced an exclusive partnership with the American Psychological Association (APA) to advance education on the benefits of digital treatments for common mental health conditions like insomnia, anxiety, and depression. Jenna Carl, PhD, practicing psychologist and Chief Medical Officer at Big Health reflects on the imporatance of this exclusive partnership with APA in an interview.

COLLABORATION PARTNERSHIP

#institution

#cbt

#pdt

View Analyst & Ambassador Comments
Go to original news
Aug 15,2023 TOP STORY

Dario Partners with PlanSource to Offer Employers Easy Access to Proven Digital Health Solutions

DarioHealth announced a new agreement with PlanSource, a leading provider of cloud-based benefits administration and engagement technology, to offer integrated digital health solutions to more than 5 million consumers. The new agreement makes it easy for employers to select and implement Dario's integrated chronic condition management solutions to employee health benefit plans as part of a curated set of benefit solutions in the PlanSource Partner Marketplace. The integration of Dario's solutions into the PlanSource Marketplace creates a seamless digital pathway for employees to engage in solutions.

COLLABORATION PARTNERSHIP

#institution

#dtx

#coaching

View Analyst & Ambassador Comments
Go to original news
Jun 29,2023

Hawaii Cancer Care Partners with Canopy

Hawaii Cancer Care has partnered with Canopy to further transform patient outcomes and experiences through continuous care delivery and the implementation of a value-based program, Principal Care Management (PCM). Using the Canopy Program Management solution, Hawaii Cancer Care was able to deploy PCM rapidly and enrolled 200 patients in just a few months, resulting in a 5x ROI. Now, Hawaii Cancer Care plans to deploy Canopy’s platform to further enhance continuous care delivery, including Canopy’s electronic patient-reported outcomes (ePRO) solution with integrated triage pathways and intelligent task management tools for remote symptom management and patient engagement.

COLLABORATION PARTNERSHIP

#institution

#rpm

View Analyst & Ambassador Comments
Go to original news
Jul 17,2023

LloydsPharmacy Clinical Homecare rolls out Careology with centralised triage system to support oncology patients

LloydsPharmacy Clinical Homecare adopts Careology's digital cancer care platform to enhance support for oncology patients. Nurses will use the system to triage patients, providing timely assessments and support, reducing hospital visits, and offering 24/7 direct access to the Oncology Nurse Specialist Team. Nurses working for LPCH, one of the leading providers in clinical homecare, will be the first to use Careology as part of a centralised system to triage patients, enabling nurses to promptly assess individuals and ascertain their specific requirements for enhanced support or urgent medical attention.

COLLABORATION PARTNERSHIP

#institution

#telehealth

#mobile app

View Analyst & Ambassador Comments
Go to original news
Subscribe to INSTITUTION